342 related articles for article (PubMed ID: 24040362)
1. A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice.
Zins K; Lucas T; Reichl P; Abraham D; Aharinejad S
PLoS One; 2013; 8(9):e74924. PubMed ID: 24040362
[TBL] [Abstract][Full Text] [Related]
2. Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity.
Zins K; Gunawardhana S; Lucas T; Abraham D; Aharinejad S
J Transl Med; 2013 Nov; 11():295. PubMed ID: 24279335
[TBL] [Abstract][Full Text] [Related]
3. R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.
Guo Y; Kenney SR; Muller CY; Adams S; Rutledge T; Romero E; Murray-Krezan C; Prekeris R; Sklar LA; Hudson LG; Wandinger-Ness A
Mol Cancer Ther; 2015 Oct; 14(10):2215-27. PubMed ID: 26206334
[TBL] [Abstract][Full Text] [Related]
4. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
[TBL] [Abstract][Full Text] [Related]
5. The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion.
Sharma A; Mendonca J; Ying J; Kim HS; Verdone JE; Zarif JC; Carducci M; Hammers H; Pienta KJ; Kachhap S
Mol Oncol; 2017 Jun; 11(6):655-669. PubMed ID: 28371345
[TBL] [Abstract][Full Text] [Related]
6. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor.
Gao Y; Dickerson JB; Guo F; Zheng J; Zheng Y
Proc Natl Acad Sci U S A; 2004 May; 101(20):7618-23. PubMed ID: 15128949
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Rac activity alleviates lipopolysaccharide-induced acute pulmonary injury in mice.
Yao HY; Chen L; Xu C; Wang J; Chen J; Xie QM; Wu X; Yan XF
Biochim Biophys Acta; 2011 Jul; 1810(7):666-74. PubMed ID: 21511011
[TBL] [Abstract][Full Text] [Related]
8. Rac1 and Cdc42 GTPases regulate shear stress-driven β-catenin signaling in osteoblasts.
Wan Q; Cho E; Yokota H; Na S
Biochem Biophys Res Commun; 2013 Apr; 433(4):502-7. PubMed ID: 23524265
[TBL] [Abstract][Full Text] [Related]
9. Metformin impairs Rho GTPase signaling to induce apoptosis in neuroblastoma cells and inhibits growth of tumors in the xenograft mouse model of neuroblastoma.
Kumar A; Al-Sammarraie N; DiPette DJ; Singh US
Oncotarget; 2014 Nov; 5(22):11709-22. PubMed ID: 25365944
[TBL] [Abstract][Full Text] [Related]
10. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
[TBL] [Abstract][Full Text] [Related]
11. Rac1 contributes to trastuzumab resistance of breast cancer cells: Rac1 as a potential therapeutic target for the treatment of trastuzumab-resistant breast cancer.
Dokmanovic M; Hirsch DS; Shen Y; Wu WJ
Mol Cancer Ther; 2009 Jun; 8(6):1557-69. PubMed ID: 19509242
[TBL] [Abstract][Full Text] [Related]
12. A role of STAT3 in Rho GTPase-regulated cell migration and proliferation.
Debidda M; Wang L; Zang H; Poli V; Zheng Y
J Biol Chem; 2005 Apr; 280(17):17275-85. PubMed ID: 15705584
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Cancer.
Humphries-Bickley T; Castillo-Pichardo L; Hernandez-O'Farrill E; Borrero-Garcia LD; Forestier-Roman I; Gerena Y; Blanco M; Rivera-Robles MJ; Rodriguez-Medina JR; Cubano LA; Vlaar CP; Dharmawardhane S
Mol Cancer Ther; 2017 May; 16(5):805-818. PubMed ID: 28450422
[TBL] [Abstract][Full Text] [Related]
14. CSRP2 suppresses colorectal cancer progression
Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the GTPase Rac1 mediates the antimigratory effects of metformin in prostate cancer cells.
Dirat B; Ader I; Golzio M; Massa F; Mettouchi A; Laurent K; Larbret F; Malavaud B; Cormont M; Lemichez E; Cuvillier O; Tanti JF; Bost F
Mol Cancer Ther; 2015 Feb; 14(2):586-96. PubMed ID: 25527635
[TBL] [Abstract][Full Text] [Related]
16. RAC1-GTP promotes epithelial-mesenchymal transition and invasion of colorectal cancer by activation of STAT3.
Zhou K; Rao J; Zhou ZH; Yao XH; Wu F; Yang J; Yang L; Zhang X; Cui YH; Bian XW; Shi Y; Ping YF
Lab Invest; 2018 Aug; 98(8):989-998. PubMed ID: 29884911
[TBL] [Abstract][Full Text] [Related]
17. Enhanced intrinsic migration of aggressive breast cancer cells by inhibition of Rac1 GTPase.
Zuo Y; Shields SK; Chakraborty C
Biochem Biophys Res Commun; 2006 Dec; 351(2):361-7. PubMed ID: 17064663
[TBL] [Abstract][Full Text] [Related]
18. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells.
Baugher PJ; Krishnamoorthy L; Price JE; Dharmawardhane SF
Breast Cancer Res; 2005; 7(6):R965-74. PubMed ID: 16280046
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia/reoxygenation-experienced cancer cell migration and metastasis are regulated by Rap1- and Rac1-GTPase activation via the expression of thymosin beta-4.
Lee JW; Ryu YK; Ji YH; Kang JH; Moon EY
Oncotarget; 2015; 6(12):9820-33. PubMed ID: 25888632
[TBL] [Abstract][Full Text] [Related]
20. ARHGAP17 inhibits pathological cyclic strain-induced apoptosis in human periodontal ligament fibroblasts via Rac1/Cdc42.
Wang L; Yang X; Wan L; Wang S; Pan J; Liu Y
Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1591-1599. PubMed ID: 32391922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]